SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
... products by Perrigo. Royalty payments are based on Perrigo's net profits from the sale of ... $473,711 in restricted cash as of June 30, 2009. based on our current operating plan, we anticipate that ... About SCOLR Pharma: based in Bothell, Washington, SCOLR Pharma, Inc. is a ...Synthetech Reports First Quarter Fiscal 2010 Results
... performance for the balance of fiscal year 2010 based on a reasonable $4.6 million order backlog, a ... Variability in Synthetech's level of revenue is based primarily on its participation in large-scale ... About Synthetech Synthetech, Inc., based in Albany, Oregon, is a fine chemicals company ...InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... information included in this press release are based on information available to InterMune as of the ... of the highest areas of interest to the company based on the prior clinical experience with pirfenidone ... States or Europe will grant regulatory approval based upon this data, in combination with the other ...PDI Reports 2009 Second Quarter Financial Results
... and financial performance. These statements are based on current expectations and assumptions involving ... materially from those set forth in this release based on the loss, early termination or significant ... actual results may differ materially based on adverse market conditions, PDI's inability to ...Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... achieved a US ADHD market share of 12.3% based on weekly prescription volumes. ADDERALL XR ... ADS for 2009 in the range of $3.00 to $3.40, were based on average actual foreign exchange rates ... earnings per ADS by $0.10 and $0.01 respectively. based on the following exchange rate scenarios, which ...ETC Biomedical Announces Chamber Sale in India
... incorporate ETC's 4(th) generation Windows(TM) based operating system that eliminates manual ... as amended. These forward-looking statements are based on ETC's current expectations and projections ... and uncertainties which are subject to change based on various important factors. Some of these risks ...Oncolytics Biotech(R) Inc. Announces 2009 Second Quarter Results
... 980,721 1,319,498 1,967,485 Stock based compensation 8,544 18,023 ... 2,370,392 26,804,510 Stock based compensation 37,616 4,789,025 ... 16,536 12,194 33,840 Stock based compensation 8,544 18,023 ...Sanofi-aventis Announces Second Quarter 2009 Results
... 26, 2009, four analyses of patient registries based on retrospective follow-up of people with ... their initial assessment of Lantus ((R)) , based on an in-depth review of existing evidence and of ... for women with metastatic breast cancer, based on the results of the AVADO study. First-half net ...PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
... Frost Group, LLC, is a private investment firm based in Miami. The Frost Group is led by Dr. Phillip ... sports licensing, aircraft leasing, fixed based aircraft operations, software for seismic data ... not succeed in developing any commercial products based upon its long-acting protein technology, ...Schering-Plough Reports Financial Results for 2009 Second Quarter
... strictly to historical or current facts and are based on current expectations or forecasts of future ... its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is ... months ended June 30, 2009 is calculated based on net income available to common shareholders ...Dow AgroSciences, NemGenix Establish New Collaboration in Plant Biotechnology
... Company (NYSE: DOW ), and NemGenix, a Perth based biotechnology company, announced today a newly ... privately held agricultural biotechnology company based at the Western Australia State Agricultural ... About Dow AgroSciences Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier ...New Pre-Clinical Data on OmniGuide's BeamPath NEURO(TM) Demonstrates Precise Cutting in Brain Tissue
... of the first and only flexible CO2 laser fiber based on breakthrough photonic bandgap technology, ... sight" procedures. OmniGuide's BeamPath fiber is based on breakthrough fiber technology developed at ... its fiber products in Cambridge, Mass. based on multi-material photonic bandgap fiber ...Cordex Completes Production of ATPace(TM) Clinical Trial Material
... that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine ... statements. The forward-looking statements are based on current expectations, estimates and ... . All forward-looking statements are based upon information available to Cordex on the date ...Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia
... company developing oral drugs to treat anemia based on discovery and development of oral agents that ... and CrystalGenomics, Inc. These statements are based on the Parties' current expectations and involve ... may choose to update this notice in the future, based on new information, future events, or otherwise, ...Sanofi Pasteur Responds to Nation's Need for Hib Vaccine With Increased Supply
... a full series of vaccinations for U.S. children. based on the increased supply, on July 1, the U.S. ... The decision to give Pentacel vaccine should be based on the potential benefits and risks; if ... The decision to give ActHIB vaccine should be based on the potential benefits and risks; if ...DuPont Adds Cotton to India Seed Product Lineup
... the cotton seed business of Nandi Seeds, based in Mehboob Nagar, Andhra Pradesh, India, and acquired cotton germplasm from Nagarjuna Seeds, based in Secunderabad, Andhra Pradesh, India. ... news release contains forward-looking statements based on management’s current expectations, ...Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
... life in any of the tests utilized in this study. based on the limited number of subjects enrolled with ... with previous studies of IPLEX(TM). based on the metabolic improvements observed in ... MMD patients with severe insulin resistance who, based on the results of this trial, may be more likely ...Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study
... submitting our data package for regulatory review based on our NDA for Restanza, which is currently under ... Rule" allows for approval of new drug products based on animal data when adequate and well-controlled ... things, indicates the product's approval was based on efficacy studies conducted in animals alone. ...BRAHMS, Cezanne and Lumiphore Announce Partnership for Diagnostic Tests
... Resolved Amplified Cryptate Emission) technology, based on Forster resonance energy transfer (FRET). - ... fluorescent-metal lanthanide detection reagents based on technology patented by Professor Kenneth N. ... are posted. About Lumiphore, Inc. based in Richmond, California, Lumiphore Inc, a ...Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion
... All statements in this news release that are not based on historical fact are "forward-looking ... of the final hearing date. While management has based any forward-looking statements contained herein ... the information on which such expectations were based may change. These forward-looking statements rely ...Israeli scientists show bacteria can plan ahead
... Mitchell devised a further test for the E. coli based on another of Pavlov's experiments. When Pavlov ... says Pilpel. What are those circumstances? based on the experimental evidence, the research team ... as well as different avenues of experimentation based on the insights they have gained. Pilpel and ...MSNBC Publishes Free Online Abridgment of 'Biocentrism'
... an exclusive online abridgment of the book based on Lanza's essay A New Theory of the Universe ... 30, 2007. Forward-looking statements are based on the beliefs, opinions, and expectations of the ... should change. Forward-looking statements are based on the beliefs, opinions, and expectations of the ...Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
... has revised its estimated date of IND filing. based on the estimated delay for completing the ... recruit the remaining patients and now believes, based on recent performance, that patient enrolment ... $18,695,000 (July 31, 2008 - $19,166,000). based on our planned expenditures and assuming no ...Frost & Sullivan Recognizes Cisbio Bioassays for Technology Innovation
... MOUNTAIN VIEW, Calif., June 9 /PRNewswire/ -- based on its recent analysis of the molecular bioassays ... over its previous generation HTRF, which was based on a Europium cryptate," notes Dr. Basu. "With the novel Tag-lite(TM) technology based on HTRF Terbium, Cisbio Bioassays has made ...PDL BioPharma Provides Second Quarter 2009 Revenue Guidance of Approximately $125 Million
... which is marketed by Elan. Royalty revenues are based on first quarter product sales by PDL's licensees ... final installment of $12.5 million from Alexion based on the companies' December 2008 settlement and ... or circumstances on which any such statements are based for any reason, except as required by law, even ...Pasteuria Bioscience Receives EPA Registration for Nematode Control
... With a robust pipeline of product candidates based on Pasteuria technology, this registration is ... for production of nematode control products based on Pasteuria technology. Pasteuria Bioscience is developing products based on Pasteuria spp. to treat major nematode pests ...